Magnocellular Neurosecretory Cells, residing in the hypothalamus, are specialized neurons crucial for regulating various physiological processes through the release of hormones. These large cells are primarily classified into two groups: oxytocin-secreting cells and vasopressin-secreting cells. Oxytocin and vasopressin, both peptide hormones, play central roles in diverse functions such as uterine contractions during childbirth, lactation, social bonding, and water balance regulation. Magnocellular neurosecretory cells produce these hormones in response to specific stimuli and release them into the bloodstream via the posterior pituitary. The secretion of oxytocin and vasopressin is finely tuned by factors like stress, dehydration, and osmotic balance. Dysfunction in magnocellular neurosecretory cell activity can lead to disorders such as diabetes insipidus or inappropriate antidiuretic hormone secretion. Understanding the regulation of magnocellular neurosecretory cells is critical for unraveling the intricacies of neuroendocrine control and holds implications for reproductive health, water balance, and stress responses. Ongoing research seeks to further elucidate the molecular mechanisms governing these cells, offering potential insights into the development of therapeutic interventions for conditions associated with hormonal dysregulation.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States